Globus Medical (GMED)
Payables turnover
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Cost of revenue | US$ in thousands | 1,035,480 | 548,174 | 263,725 | 239,223 | 217,463 |
Payables | US$ in thousands | — | — | — | — | — |
Payables turnover | — | — | — | — | — |
December 31, 2024 calculation
Payables turnover = Cost of revenue ÷ Payables
= $1,035,480K ÷ $—K
= —
Based on the provided data for Globus Medical, the payables turnover ratio is not available for the years ending December 31, 2020, 2021, 2022, 2023, and 2024. This means that we do not have specific information on how efficiently the company is managing its accounts payable during those periods. The payables turnover ratio is a key metric that helps assess how quickly a company pays off its suppliers. In the absence of this data, we are unable to evaluate Globus Medical's payment practices and the efficiency of its working capital management in relation to its suppliers.
Peer comparison
Dec 31, 2024
Company name
Symbol
Payables turnover
Globus Medical
GMED
—
3M Company
MMM
5.43
Artivion Inc
AORT
—
Baxter International Inc
BAX
—
Becton Dickinson and Company
BDX
9.39
Boston Scientific Corp
BSX
—
DexCom Inc
DXCM
—
Embecta Corp
EMBC
5.72
Glaukos Corp
GKOS
29.35
Haemonetics Corporation
HAE
16.02
ICU Medical Inc
ICUI
—